0.05). The protection level of RB51 was sacrificed when the values of several variables (e.g., vaccination route, vaccine viability, and challenge pathogen strain) change. It is suggestive that it is difficult to protect against aerosol challenge. Somewhat counter-intuitively, our results indicate that intraperitoneal and subcutaneous vaccinations are much more effective to protect against aerosol Brucella challenge than intranasal vaccination. Conclusions Literature meta-analysis identified variables that significantly contribute to Brucella vaccine protection efficacy. The results obtained provide critical information for rational vaccine study design. Literature meta-analysis is generic and can be applied to analyze variables critical for vaccine protection against other infectious diseases."/>
# | Variables | Df | Sum Square | Mean Square | F value | P-value (>F) |
---|---|---|---|---|---|---|
Variables with statistically significant contribution to protection (P-value < 0.05) | ||||||
1 | CFU Reduction | 1 | 4.32 | 4.32 | 58.66 | 1.574E-13 |
2 | Pathogen challenge route | 1 | 2.20 | 2.20 | 29.90 | 8.278E-08 |
3 | Vaccine dose | 1 | 1.77 | 1.77 | 24.09 | 1.369E-06 |
4 | CFU in spleen | 1 | 0.92 | 0.92 | 12.49 | 4.591E-04 |
5 | Challenge Pathogen Strain | 1 | 0.85 | 0.85 | 11.54 | 0.0008 |
6 | Mouse strain | 1 | 0.58 | 0.58 | 7.86 | 0.0053 |
7 | Vaccine strain | 1 | 0.41 | 0.41 | 5.56 | 0.0188 |
8 | Vaccination route | 1 | 0.41 | 0.41 | 5.54 | 0.0190 |
9 | Challenge-killing Interval | 1 | 0.38 | 0.38 | 5.19 | 0.0232 |
Variables without statistically significant contribution to protection (P-value > 0.05) | ||||||
10 | Vaccination Frequency | 1 | 0.27 | 0.27 | 3.61 | 0.0581 |
11 | Adjuvant | 1 | 0.18 | 0.18 | 2.41 | 0.1215 |
12 | Vaccination Challenge Interval | 1 | 0.16 | 0.16 | 2.20 | 0.1385 |
13 | Gene Mutation | 1 | 0.12 | 0.12 | 1.68 | 0.1951 |
14 | Mouse Age at Vaccination | 1 | 0.07 | 0.07 | 0.97 | 0.3244 |
15 | Sample Size | 1 | 0.03 | 0.03 | 0.47 | 0.4928 |
16 | Vaccine viability | 1 | 0.02 | 0.02 | 0.34 | 0.5612 |
17 | Antigen Overexpression | 1 | 0.02 | 0.02 | 0.23 | 0.6299 |
18 | Mouse Sex | 1 | 0.01 | 0.01 | 0.10 | 0.7499 |
19 | Challenge Dose | 1 | 0.00 | 0.00 | 0.07 | 0.7988 |